Literature DB >> 24980199

Prostate cancer: Rescreening policies and risk calculators.

Monique J Roobol1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24980199     DOI： 10.1038/nrurol.2014.142

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  9 in total

1.  A "PSA pyramid" for men with initial prostate-specific antigen ≤3 ng/ml: a plea for individualized prostate cancer screening.

Authors:  Marco Randazzo; Josef Beatrice; Andreas Huber; Rainer Grobholz; Lukas Manka; Felix K Chun; Franz Recker; Maciej Kwiatkowski
Journal:  Eur Urol       Date:  2014-04-18       Impact factor: 20.096

2.  Balancing the harms and benefits of early detection of prostate cancer.

Authors:  Pim J van Leeuwen; David Connolly; Teuvo L J Tammela; Anssi Auvinen; Ries Kranse; Monique J Roobol; Fritz H Schroder; Anna Gavin
Journal:  Cancer       Date:  2010-10-15       Impact factor: 6.860

3.  Prostate-cancer mortality at 11 years of follow-up.

Authors:  Fritz H Schröder; Jonas Hugosson; Monique J Roobol; Teuvo L J Tammela; Stefano Ciatto; Vera Nelen; Maciej Kwiatkowski; Marcos Lujan; Hans Lilja; Marco Zappa; Louis J Denis; Franz Recker; Alvaro Páez; Liisa Määttänen; Chris H Bangma; Gunnar Aus; Sigrid Carlsson; Arnauld Villers; Xavier Rebillard; Theodorus van der Kwast; Paula M Kujala; Bert G Blijenberg; Ulf-Hakan Stenman; Andreas Huber; Kimmo Taari; Matti Hakama; Sue M Moss; Harry J de Koning; Anssi Auvinen
Journal:  N Engl J Med       Date:  2012-03-15       Impact factor: 91.245

4.  Prostate cancer incidence and disease-specific survival of men with initial prostate-specific antigen less than 3.0 ng/ml who are participating in ERSPC Rotterdam.

Authors:  Meelan Bul; Pim J van Leeuwen; Xiaoye Zhu; Fritz H Schröder; Monique J Roobol
Journal:  Eur Urol       Date:  2011-02-18       Impact factor: 20.096

5.  A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam.

Authors:  Monique J Roobol; Xiaoye Zhu; Fritz H Schröder; Geert J L H van Leenders; Ron H van Schaik; Chris H Bangma; Ewout W Steyerberg
Journal:  Eur Urol       Date:  2012-07-20       Impact factor: 20.096

Review 6.  Risk stratification in prostate cancer screening.

Authors:  Monique J Roobol; Sigrid V Carlsson
Journal:  Nat Rev Urol       Date:  2012-12-18       Impact factor: 14.432

7.  A graphical device to represent the outcomes of a logistic regression analysis.

Authors:  Ries Kranse; Monique Roobol; Fritz H Schröder
Journal:  Prostate       Date:  2008-11-01       Impact factor: 4.104

8.  Screening for prostate cancer: results of the Rotterdam section of the European randomized study of screening for prostate cancer.

Authors:  Monique J Roobol; Ries Kranse; Chris H Bangma; Arno G J L H van Leenders; Bert G Blijenberg; Ron H N van Schaik; Wim J Kirkels; Suzie J Otto; Theo H van der Kwast; Harry J de Koning; Fritz H Schröder
Journal:  Eur Urol       Date:  2013-05-25       Impact factor: 20.096

9.  Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative group.

Authors:  Monique J Roobol; F H Schröder; Jonas Hugosson; J Stephen Jones; Michael W Kattan; Eric A Klein; Freddie Hamdy; David Neal; Jenny Donovan; Dipen J Parekh; Donna Ankerst; George Bartsch; Helmut Klocker; Wolfgang Horninger; Amine Benchikh; Gilles Salama; Arnauld Villers; Stephen J Freedland; Daniel M Moreira; Andrew J Vickers; Hans Lilja; Ewout W Steyerberg
Journal:  World J Urol       Date:  2011-12-28       Impact factor: 4.226
  9 in total
  2 in total

Review 1.  What's new in screening in 2015?

Authors:  Sigrid V Carlsson; Monique J Roobol
Journal:  Curr Opin Urol       Date:  2016-09       Impact factor: 2.309

2.  External Evaluation of a Novel Prostate Cancer Risk Calculator (ProstateCheck) Based on Data from the Swiss Arm of the ERSPC.

Authors:  Cédric Poyet; Marian S Wettstein; Dara J Lundon; Bimal Bhindi; Girish S Kulkarni; Karim Saba; Tullio Sulser; A J Vickers; Thomas Hermanns
Journal:  J Urol       Date:  2016-05-14       Impact factor: 7.450
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.